Price movement over the last 24 hours
Align Technology, Inc. vs T-Mobile Us Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while T-Mobile Us Inc trades at $189.79 (market cap $203.03B). The key difference: T-Mobile Us Inc is far larger — about 15.8× Align Technology, Inc.'s market cap, and T-Mobile Us Inc pays a 2.17% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | TMUS | |
|---|---|---|
Market Cap | $12.86B | $203.03B |
Sector | Health | Media |
52-Week High | $207.19 | $259.01 |
52-Week Low | $124.88 | $167.65 |
Enterprise Value | $11.92B | $320.73B |
Dividend Yield | — | 2.17% |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
T-Mobile US (TMUS) trades at $187.61, up 3.38% on the day, with a neutral technical signal and strong analyst support. The stock shows robust fundamentals with 2025 revenue of $88.31B, net income of $10.99B, and consistent cash flow generation. Recent leadership changes and competitive threats from SpaceX's potential market entry are key developments. Valuation metrics include a P/E of 19.94 and P/S of 2.32, while the consensus price target is $244.50, suggesting significant upside potential.
The outlook for TMUS is positive due to strong earnings beats, healthy profitability margins, and growth in postpaid accounts. Risks include rising debt levels, intense competition, and capital expenditure pressures. With 83% of analysts rating it a Buy, the stock presents a compelling opportunity for long-term investors, though monitoring competitive dynamics and interest expense trends is crucial.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.
Read more on TMUS →